LG Chem's corporate bonds attracted 4 trillion won... 'A' class Hyosung Chemical suffered a crushing defeat

Reporter Kim Jisun / approved : 2023-01-17 19:56:21
  • -
  • +
  • 인쇄
This article is translated by AI company Flitto and Alhpabiz neural machine translation technology

[Alphabiz=(Chicago) Reporter Kim Jisun] Hyosung Chemical (A), which appeared in the public offering market as its first A-class corporate bond this year, suffered the disgrace of not selling its first demand forecast this year. On the other hand, nearly 4 trillion won was attracted to LG Chem (AA+), an AA-class blue-chip bond that conducted demand forecasts together. Since the beginning of the year, the polarization of blue-chip and non-performing bonds has been extreme.

According to the financial investment industry on the 17th, Hyosung Chemical made a demand forecast for a total of 120 billion won, including 70 billion won for 1.5 years and 50 billion won for two years, with a total of 70 billion won in orders. With the non-sale of 50 billion won, Hyosung Chemical will start additional recruitment for the unsold volume.

If you look at the content, it is more pessimistic. The 70 billion won order was also supported by the Korea Development Bank. Hyosung Chemical was initially supported by the Korea Development Bank to buy some supplies if there was no sale in its demand forecast, which was all it had entered into its demand forecast. As Hyosung Chemical's credit rating is Class A, the bond market stabilization fund, which can only contain Class AA, also failed to operate.

Hyosung Chemical presented an interest rate of -50bp (Basys Point, 1bp = 0.01% point) to +100bp in this demand forecast, but was shunned by the market. The financial burden seems to have played a negative role in Hyosung Chemical's demand forecast.

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

[Exclusive] Samsung Electronics Passes NVIDIA’s HBM3E 12-High Qualification Test, Secures Supply Deal2025.09.19
Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions2025.09.19
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response2025.09.19
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group2025.09.19
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties2025.09.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사